Zurück

Wählen Sie Ihre Region

Corporate

Europa:

Flagge Albanien Albanien Flagge Bosnien-Herzegowina Bosnien-Herzegowina Flagge Bulgarien Bulgarien Flagge Kroatien Kroatien Flagge Zypern Zypern Flagge Montenegro Montenegro Flagge Tschechien Tschechien Flagge Dänemark Dänemark Flagge Estland Estland Flagge Spanien Spanien Flagge Kosovo Kosovo Flagge Litauen Litauen Flagge Lettland Lettland Flagge Luxemburg Luxemburg Flagge Mazedonien Mazedonien Flagge Deutschland Deutschland Flagge Polen Polen Flagge Portugal Portugal Flagge Rumänien Rumänien Flagge Serbien Serbien Flagge Slowakei Slowakei Flagge Slowenien Slowenien Flagge Schweiz Schweiz Flagge Schweden Schweden Flagge Türkei Türkei Flagge Ungarn Ungarn Flagge Großbritannien Großbritannien Flagge Italien Italien

Asien:

Flagge UAE UAE Flagge Hong Kong Hong Kong Flagge Kuwait Kuwait Flagge Libanon Libanon

Afrika:

Flagge Südafrika Südafrika

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Kontaktieren Sie uns noch heute!

Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.

    Wir möchten Sie darauf hinweisen, dass die im Formular angegebenen personenbezogenen Daten von FamiCord Suisse mit Sitz in der Schweiz (BusinessPark Zug Sumpfstrasse 26, 6302 Zug) zur telefonischen Kontaktaufnahme im Zusammenhang mit der Erteilung von Serviceinformationen verarbeitet werden.

    Obraz

    Unsere
    Transplantationen

    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

    Obraz
    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
    Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
    3101 Apheresis Allogeneic Multiple Myeloma – Relapse Hematology 2022 Standard Therapy Germany 43
    3102 Apheresis Autologous Multiple Myeloma Angioimmunoblastic T-Cell Lymphoma Hematology 2022 Standard Therapy Germany 62
    3103 Apheresis Allogeneic Mycosis Fungoides Hematology 2022 Standard Therapy Poland 64
    3104 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
    3105 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 69
    3106 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 76
    3107 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 45
    3108 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 63
    3109 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 72
    3110 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 70
    3111 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 45
    3112 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 73
    3113 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 21
    3114 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 46
    3115 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 64
    3116 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 71
    3117 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 49
    3118 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
    3119 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 63
    3120 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 71
    3121 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 72
    3122 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 33
    3123 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 3
    3124 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
    3125 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 16
    3126 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 66
    3127 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 64
    3128 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 71
    3129 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
    3130 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 48
    3131 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
    3132 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 48
    3133 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 73
    3134 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 69
    3135 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 79
    3136 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 54
    3137 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 44
    3138 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 63
    3139 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 56
    3140 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
    3141 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 72
    3142 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
    3143 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 64
    3144 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 65
    3145 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 70
    3146 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 66
    3147 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 88
    3148 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 67
    3149 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 52
    3150 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 57
    3151 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 62
    3152 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 36
    3153 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 61
    3154 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 11
    3155 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Germany 61
    3156 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb2 Hematology 2022 Standard Therapy Poland 62
    3157 Apheresis Allogeneic Myelodysplastic Syndrome Rc Hematology 2022 Standard Therapy Poland 3
    3158 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Blasts 1 Hematology 2022 Standard Therapy Poland 59
    3159 Apheresis Allogeneic Myelodysplastic Syndrome With Excess Blasts 2 Hematology 2022 Standard Therapy Poland 67
    3160 Apheresis Allogeneic Myelodysplastic Syndrome With Fibrosis Hematology 2022 Standard Therapy Poland 72
    3161 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 58
    3162 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 69
    3163 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 57
    3164 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 64
    3165 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 73
    3166 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 67
    3167 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 66
    3168 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 69
    3169 Apheresis Allogeneic Myelofibrosis Hematology 2022 Standard Therapy Poland 60
    3170 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 69
    3171 Apheresis Allogeneic Myelofibrosis Post Essential Thrombocythemia Hematology 2022 Standard Therapy Poland 64
    3172 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 58
    3173 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 72
    3174 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2022 Standard Therapy Poland 73
    3175 Apheresis Autologous Myeloma Hematology 2022 Standard Therapy Germany 54
    3176 Apheresis Allogeneic Myeloma Multiplex Hematology 2022 Standard Therapy Poland 31
    3177 Apheresis Allogeneic Myeloproliferative Neoplasms With Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 59
    3178 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 50
    3179 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 37
    3180 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 64
    3181 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 59
    3182 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 21
    3183 Apheresis Allogeneic No Data Hematology 2022 Standard Therapy Poland 38
    3184 Apheresis Autologous Nodular Lymphocyte Predominant Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 31
    3185 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 73
    3186 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 61
    3187 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 53
    3188 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 18
    3189 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 28
    3190 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 55
    3191 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 59
    3192 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 52
    3193 Apheresis Allogeneic Osteomyelofibrosis Hematology 2022 Standard Therapy Poland 59
    3194 Apheresis Allogeneic Osteomyelofibrosis Hematology 2022 Standard Therapy Poland 59
    3195 Apheresis Allogeneic Other Immune System Hematology 2022 Standard Therapy Poland 46
    3196 Apheresis Allogeneic Other Malignancy Hematology 2022 Standard Therapy Poland 72
    3197 Apheresis Allogeneic Peripheral T-Cell Lymphoma Hematology 2022 Standard Therapy Poland 32
    3198 Apheresis Allogeneic Plasma Cell Disorder Hematology 2022 Standard Therapy Poland 56
    3199 Apheresis Allogeneic Plasma Cell Leukemia Hematology 2022 Standard Therapy Poland 58
    3200 Apheresis Allogeneic Post-Essential Thrombocythemia-Myelofibrosis Hematology 2022 Standard Therapy Poland 64